EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Astaxanthin Alleviates Hepatic Lipid Metabolic Dysregulation Induced by Microcystin-LR

Qinmei Tan iD, Hanyu Chu, Jia Wei, Sisi Yan, Xiaoya Sun, Jiangping Wang, Lemei Zhu, Fei Yang iD

Toxins · 18.09.2024 · 16 (9) · 401

DOI: 10.3390/toxins16090401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, online erschienen am 18.09.2024. Verfasst von Qinmei Tan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Province Key Laboratory of Typical Environmental Pollution and Health Hazards, School of Public Health, Hengyang Medical School, University of …. Hauptthemen laut MEDLINE: Microcystins, Xanthophylls, Marine Toxins, Lipid Metabolism. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Hunan Province Key Research and Development Projects, the Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microcystin-LR (MC-LR), frequently generated by cyanobacteria, has been demonstrated to raise the likelihood of liver disease. Few previous studies have explored the potential antagonist against MC-LR. Astaxanthin (ASX) has been shown to possess various beneficial effects in regulating lipid metabolism in the liver. However, whether ASX could alleviate MC-LR-induced hepatic lipid metabolic dysregulation is as yet unclear. In this work, the important roles and mechanisms of ASX in countering MC-LR-induced liver damage and lipid metabolic dysregulation were explored for the first time. The findings revealed that ASX not only prevented weight loss but also enhanced liver health after MC-LR exposure. Moreover, ASX effectively decreased triglyceride, total cholesterol, aspartate transaminase, and alanine aminotransferase contents in mice that were elevated by MC-LR. Histological observation showed that ASX significantly alleviated lipid accumulation and inflammation induced by MC-LR. Mechanically, ASX could significantly diminish the expression of genes responsible for lipid generation (Srebp-1c, Fasn, Cd36, Scd1, Dgat1, and Pparg), which probably reduced lipid accumulation induced by MC-LR. Analogously, MC-LR increased intracellular lipid deposition in THLE-3 cells, while ASX decreased these symptoms by down-regulating the expression of key genes in the lipid synthesis pathway. Our results implied that ASX played a crucial part in lipid synthesis and effectively alleviated MC-LR-induced lipid metabolism dysregulation. ASX might be developed as a novel protectant against hepatic impairment and lipid metabolic dysregulation associated with MC-LR. This study offers new insights for further management of MC-LR-related metabolic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrocystinsXanthophyllsMarine ToxinsLipid MetabolismLiverAnimalsMiceMaleMice, Inbred C57BLCell LineChemical and Drug Induced Liver Injury

Stichwörter der Autor:innen

astaxanthinlipid metabolismliver damagemicrocystin-LR

Substanzen

Microcystinscyanoginosin LRastaxanthineXanthophyllsMarine Toxins

Autor:innen und Institutionen

  • Hunan Province Key Laboratory of Typical Environmental Pollution and Health Hazards, School of Public Health, Hengyang Medical School, University of South China, Hengyang 421001, China.
  • Hengyang Maternal and Child Health Hospital, Hengyang 421001, China.
  • Xiangya School of Public Health, Central South University, Changsha 410078, China.
  • Hunan Engineering Research Center of Livestock and Poultry Health Care, Colleges of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China.
  • School of Public Health, Changsha Medical University, Changsha 410219, China.
  • Affiliated Nanhua Hospital University of South China, Hengyang 421000, China.

ORCID-Profile: Qinmei Tan, Fei Yang

Förderung

  • the Hunan Province Key Research and Development Projects
  • the Natural Science Foundation of Hunan Province

Zitieren

APA

Tan, Q., Chu, H., Wei, J., Yan, S., Sun, X., Wang, J., Zhu, L., & Yang, F. (2024). Astaxanthin Alleviates Hepatic Lipid Metabolic Dysregulation Induced by Microcystin-LR. Toxins, 16(9), 401. https://doi.org/10.3390/toxins16090401

Vancouver

Tan Q, Chu H, Wei J, Yan S, Sun X, Wang J, et al. Astaxanthin Alleviates Hepatic Lipid Metabolic Dysregulation Induced by Microcystin-LR. Toxins. 2024;16(9):401. doi:10.3390/toxins16090401

BibTeX
@article{Tan2024,
  author = {Tan, Qinmei and Chu, Hanyu and Wei, Jia and Yan, Sisi and Sun, Xiaoya and Wang, Jiangping and Zhu, Lemei and Yang, Fei},
  title = {Astaxanthin Alleviates Hepatic Lipid Metabolic Dysregulation Induced by Microcystin-LR},
  journal = {Toxins},
  year = {2024},
  volume = {16},
  number = {9},
  pages = {401},
  doi = {10.3390/toxins16090401}
}
Kostenlos starten →